Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection.

PubWeight™: 2.35‹?› | Rank: Top 2%

🔗 View Article (PMID 2121030)

Published in Am J Med on October 01, 1990

Authors

F Kramer1, T Modilevsky, A R Waliany, J M Leedom, P F Barnes

Author Affiliations

1: Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

Articles citing this

Evaluation of acridinium-ester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture. J Clin Microbiol (1991) 3.88

Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg (2006) 2.05

Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85

Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol (1998) 1.60

Automatic screening for tuberculosis in chest radiographs: a survey. Quant Imaging Med Surg (2013) 1.42

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS (2012) 1.40

Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J Clin Microbiol (1997) 1.37

Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J Virol (2002) 1.27

Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev (1994) 1.19

The utility of stool cultures for diagnosing tuberculosis in people living with the human immunodeficiency virus. Int J Tuberc Lung Dis (2013) 1.18

Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases. CMAJ (1992) 1.15

Evolving approaches to management of quality in clinical microbiology. Clin Microbiol Rev (1994) 1.11

Missed opportunities in TB diagnosis: a TB process-based performance review tool to evaluate and improve clinical care. BMC Public Health (2011) 1.06

Time to first consultation, diagnosis and treatment of TB among patients attending a referral hospital in Northwest, Ethiopia. BMC Infect Dis (2014) 1.02

Controlling tuberculosis in an urban emergency department: a rapid decision instrument for patient isolation. Am J Public Health (1997) 1.01

Essentials of tuberculosis control for the practising physician. Tuberculosis Committee, Canadian Thoracic Society. CMAJ (1994) 1.00

Factors associated with delayed diagnosis of tuberculosis in hospitalized patients in a high TB and HIV burden setting: a cross-sectional study. BMC Infect Dis (2012) 0.97

Delayed diagnosis and associated factors among new pulmonary tuberculosis patients diagnosed at the emergency department of a tertiary care hospital in Porto Alegre, South Brazil: a prospective patient recruitment study. BMC Infect Dis (2013) 0.95

Tuberculosis and HIV disease: two decades of a dual epidemic. Wien Klin Wochenschr (2003) 0.93

U.S. medical resident familiarity with national tuberculosis guidelines. BMC Infect Dis (2007) 0.85

Direct diagnosis ofMycobacterium tuberculosis in blood samples of HIV infected patients by polymerase chain reaction. Indian J Clin Biochem (2000) 0.76

Associated factors for treatment delay in pulmonary tuberculosis in HIV-infected individuals: a nested case-control study. BMC Infect Dis (2012) 0.76

Pulmonary Tuberculosis in HIV Infection : The Relationship of the Radiographic Appearance to CD4 T-Lymphocytes Count. Malays J Med Sci (2001) 0.75

A COMPARATIVE STUDY OF CHEST RADIOGRAPHIC FEATURES BETWEEN HIV SEROPOSITIVE AND HIV SERONEGATIVE PATIENTS OF PULMONARY TUBERCULOSIS. Med J Armed Forces India (2011) 0.75

Delayed diagnosis of HIV-related tuberculosis. Am J Med (1991) 0.75

Mycobacterial infections in AIDS. Can J Infect Dis (1991) 0.75

Articles by these authors

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis (1993) 4.01

Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52

Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1999) 3.45

Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39

The critically ill child: management of acute bacterial meningitis. Pediatrics (1969) 2.84

T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57

A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57

T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51

Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol (1998) 2.49

A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med (1990) 2.48

Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis (1999) 2.29

Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis (1999) 2.04

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1994) 1.99

Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98

Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85

Importance of sulfadiazine resistance in meningococcal disease in civilians. N Engl J Med (1965) 1.80

Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies. Am J Dis Child (1969) 1.79

Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med (1997) 1.76

Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74

Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis (1997) 1.70

IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65

Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet (1997) 1.65

Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun (1998) 1.58

Meningitis due to Listeria monocytogenes. A review of 25 cases. N Engl J Med (1971) 1.57

Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med (2001) 1.53

Evaluation of method for secondary DNA typing of Mycobacterium tuberculosis with pTBN12 in epidemiologic study of tuberculosis. J Clin Microbiol (1996) 1.52

Prevalence of neurosyphilis in human immunodeficiency virus-infected patients with latent syphilis. Am J Med (1992) 1.52

Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51

Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med (1996) 1.43

Undiagnosed tuberculosis in patients with human immunodeficiency virus infection. Chest (1990) 1.41

Rapid diagnostic tests for tuberculosis: progress but no gold standard. Am J Respir Crit Care Med (1997) 1.40

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. Ann Intern Med (1992) 1.36

Susceptibility of Hemophilus influenzae, type b, to ampicillin at Los Angeles County/University of Southern California Medical Center. A reappraisal after ten years. J Pediatr (1975) 1.34

Observations of the staphylococcal nasal carrier state. Ann N Y Acad Sci (1965) 1.34

CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis (1997) 1.32

Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol (1997) 1.30

Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun (1998) 1.29

Rattlesnake capsule-associated Salmonella arizona infections. Arch Intern Med (1988) 1.27

The problem of sulfadiazine-resistant meningococci. Antimicrob Agents Chemother (Bethesda) (1966) 1.27

Protease inhibitor-associated hyperglycaemia. Lancet (1997) 1.26

Correlates of sulfadiazine resistance in meningococci isolated from civilians. Antimicrob Agents Chemother (Bethesda) (1965) 1.22

Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b. J Infect Dis (1978) 1.22

Antibiotic antagonism in bacterial meningitis. Antimicrob Agents Chemother (Bethesda) (1967) 1.20

Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics. Rev Infect Dis (1984) 1.20

Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med (1989) 1.15

Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis (2001) 1.15

Predictors of short-term prognosis in patients with pulmonary tuberculosis. J Infect Dis (1988) 1.15

Important assumptions, extrapolations, and established facts which underlie the use of live rubella virus vaccines. Am J Epidemiol (1970) 1.13

Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas. J Clin Microbiol (1999) 1.13

Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med (1993) 1.11

The T cell receptors of human gamma delta T cells reactive to Mycobacterium tuberculosis are encoded by specific V genes but diverse V-J junctions. J Immunol (1991) 1.11

Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis (2000) 1.10

Evidence for a superantigen in human tuberculosis. Immunity (1994) 1.10

Chest roentgenogram in pulmonary tuberculosis. New data on an old test. Chest (1988) 1.09

Experience with ampicillin in bacterial meningitis. Antimicrob Agents Chemother (Bethesda) (1965) 1.09

Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun (2000) 1.08

Antimycobacterial antibody levels in pleural fluid as reflection of passive diffusion from serum. Chest (1990) 1.07

Pleuritis as a manifestation of reactivation tuberculosis. Am J Med (1990) 1.06

Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis (1996) 1.05

Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis. Infect Immun (2000) 1.04

Comparative trial of carbenicillin and ampicillin therapy for purulent meningitis. Antimicrob Agents Chemother (1977) 1.03

Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab (1989) 1.02

Testing for human immunodeficiency virus infection among tuberculosis patients in Los Angeles. Am J Respir Crit Care Med (1997) 1.02

A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy. Clin Infect Dis (2001) 1.01

Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol (1999) 0.98

Six cases of Mycobacterium tuberculosis bacteremia. J Infect Dis (1987) 0.95

Medical treatment of hepatic amebic abscess: rare need for percutaneous drainage. Radiology (1987) 0.95

A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group. J Infect Dis (1997) 0.95

Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest (1992) 0.95

Effects of Mycobacterium tuberculosis on the bioelectric properties of the alveolar epithelium. Infect Immun (1997) 0.94

A case of melioidosis originating in North America. Am Rev Respir Dis (1986) 0.94

Sonographic features of amebic and pyogenic liver abscesses: a blinded comparison. AJR Am J Roentgenol (1987) 0.94

The influence of epidemiologic factors on drug resistance rates in tuberculosis. Am Rev Respir Dis (1987) 0.93

The immunology of tuberculous pleurisy. Semin Respir Infect (1988) 0.92

Ampicillin levels in the cerebrospinal fluid during treatment of bacterial meningitis. Antimicrob Agents Chemother (Bethesda) (1965) 0.92

Type 1 cytokines and the pathogenesis of tuberculosis. Am J Respir Crit Care Med (2000) 0.91

Abdominal tuberculosis in patients infected with the human immunodeficiency virus. Clin Infect Dis (1995) 0.90

Production of interleukin-18 in human tuberculosis. J Infect Dis (2000) 0.90

Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection. J Clin Invest (1998) 0.90

Bacterial meningitis. Ann N Y Acad Sci (1967) 0.90

Combined toxicity of zidovudine and antituberculosis chemotherapy. Am Rev Respir Dis (1992) 0.89

IL12 and the human immune response to mycobacteria. Res Immunol (1996) 0.89

Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis. Infect Immun (2001) 0.88

The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis (1994) 0.88

Reducing ongoing transmission of tuberculosis. JAMA (1998) 0.87

Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann Intern Med (1991) 0.86

Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group. Control Clin Trials (1993) 0.86

Cytokine production in children with tuberculous infection and disease. Clin Infect Dis (1999) 0.86

Clinical rubella with arthritis resulting from reinfection. Ann Intern Med (1972) 0.86

A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection. Am J Respir Crit Care Med (1994) 0.85

The frequency of Legionella infection prospectively determined in children hospitalized with pneumonia. J Pediatr (1981) 0.85

An unusual case of tuberculous peritonitis in a man with AIDS. West J Med (1986) 0.84

Tuberculosis mimicking acute appendicitis in patients with human immunodeficiency virus infection. Clin Infect Dis (1994) 0.83

Immunohistology of tuberculous adenitis in symptomatic HIV infection. Clin Exp Immunol (1988) 0.83

T cells enhance production of IL-18 by monocytes in response to an intracellular pathogen. J Immunol (2001) 0.83